Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry
申请人:SYNTEX (U.S.A.) INC.
公开号:EP0126449A1
公开(公告)日:1984-11-28
Novel compounds of the general formula
and the pharmaceutically acceptable esters and acid addition salts thereof, wherein:
R1, R2, R3, R4, and R5 are each independently hydrogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, N-optionally substituted alkylamido, except that when R1 is methyl, R4 is not methyl; or
R2 and R3 together form -OCH2O-;
R6, R7, R8, R9 and R10 are each independently hydrogen, lower acyl, aminocarbonyl-methyl, arylcyano, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, di-lower alkyl amino; or
R6 and R7 together form -CH = CH-CH = CH-;
R7 and R8 together form -OCH2O -;
R11 and R12 are each independently hydrogen or lower alkyl; and
W is oxygen or sulfur.
These cardioselective compounds have calcium entry blockade properties and therefore are useful in therapy in the treatment of cardiovascular diseases, including arrhythmias, variant and exercise induced angina and myocardial infarction.
通式为
及其药学上可接受的酯和酸加成盐,其中
R1、R2、R3、R4 和 R5 各自独立地为氢、低级烷基、低级烷氧基、氰基、三氟甲基、卤代、低级烷硫基、低级烷基亚磺酰基、低级烷基磺酰基、N-可选取代的烷基氨基,但当 R1 为甲基时,R4 不是甲基;或
R2 和 R3 共同形成 -OCH2O-;
R6、R7、R8、R9 和 R10 各自独立地为氢、低级酰基、氨基羰基甲基、芳基氰基、低级烷基、低级烷氧基、三氟甲基、卤代、低级烷硫基、低级烷基亚磺酰基、低级烷基磺酰基、二低级烷基氨基;或
R6 和 R7 共同形成 -CH = CH-CH = CH-;
R7 和 R8 共同形成 -OCH2O -;
R11 和 R12 各自独立地为氢或低级烷基;以及
W 是氧或硫。
这些心脏选择性化合物具有钙离子进入阻断特性,因此可用于治疗心血管疾病,包括心律失常、变异型和运动诱发的心绞痛和心肌梗塞。